<DOC>
	<DOC>NCT02095574</DOC>
	<brief_summary>A pharmacokinetic study to access how the body absorbs and removes ABT-199 in adults with Non-Hodgkin's Lymphoma.</brief_summary>
	<brief_title>A Pharmacokinetic Study to Access How the Body Absorbs and Removes ABT-199 in Adults With Non-Hodgkin's Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
	<criteria>1. Subject must have relapsed or refractory disease. 2. Subject must have histologically documented diagnosis of nonhodgkin's lymphoma as defined by a Bcell neoplasm in the World Health Organization (WHO) classification scheme except as noted in exclusion criteria. 3. Subject has an Eastern Cooperative Oncology Group (ECOG) performance score of 02. 4. Subject has adequate bone marrow (independent of growth factor support per local laboratory reference range). 5. Subject has adequate coagulation, renal and hepatic function. 1. Subject has been diagnosed with PostTransplant Lymphoproliferative Disease (PTLD), Burkitt's lymphoma, Burkittlike lymphoma, lymphoblastic lymphoma/leukemia, chronic lymphocytic leukemia (CLL), mantle cell leukemia (MCL), or small lymphocytic lymphoma (SLL). 2. Subject has undergone an allogeneic stem cell transplant. 3. Subject is receiving combination antiretroviral therapy for human immunodeficiency virus (HIV) (due to potential drugdrug interactions, as well as the potential for increased risk of opportunistic infections). 4. Subject has a significant history of renal, neurologic, psychiatric, endocrinologic, metabolic, immunologic, cardiovascular, or hepatic disease within 6 months that in the opinion of the Investigator would adversely affect his/her participation in this study. 5. Subject has active peptic ulcer disease or other hemorrhagic esophagitis/gastritis.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>GDC-0199</keyword>
	<keyword>ADME</keyword>
	<keyword>Relapsed</keyword>
	<keyword>Refractory</keyword>
	<keyword>ABT-199</keyword>
	<keyword>Non-Hodgkin's Lymphoma</keyword>
</DOC>